Botulinum toxin injection for retrograde cricopharyngeal muscle dysfunction syndrome.

Date publication

décembre 2024

Journal

European annals of otorhinolaryngology, head and neck diseases

Auteurs

Membres identifiés du Cancéropôle Est :
Pr DEBRY Christian , Pr SCHULTZ Philippe , Dr FATH Léa

Tous les auteurs :
Thibault C, Mailly M, Debry C, Schultz P, Fath L

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/39701874

Résumé

Retrograde cricopharyngeal dysfunction (RCPD) syndrome renders patients unable to belch, causing disabling symptoms that impact quality of life. Injection of botulinum toxin into the cricopharyngeal muscle has been reported as a trial treatment for both therapeutic and diagnostic purposes. We describe the injection technique, under general anesthesia using endoscopy or by transcutaneous injection with electromyographic control.

Mots clés

Botulinum toxin, Quality of life, RCPD

Référence

Eur Ann Otorhinolaryngol Head Neck Dis. 2024 12 18;: